Option Care Health Inc (NAS:OPCH)

Q1 2025 Option Care Health Inc Earnings Call Transcript

Apr 29, 2025 / 12:30 PM GMT

Release Date Price: $30.69 (-6.92%)

Transcript 10-Q8-K

Key Points

Positve

Option Care Health Inc (OPCH) reported robust growth in its acute portfolio, contributing to a positive financial performance.
The company successfully managed inventory levels, particularly with Stelara, which helped mitigate potential economic impacts.
Option Care Health Inc (OPCH) demonstrated strong execution in transitioning patients from hospitals to home care, enhancing its value proposition to payer partners.
The company is leveraging technology and AI to improve revenue cycle management and reduce bad debt, enhancing operational efficiency.
Option Care Health Inc (OPCH) maintains a diversified portfolio of therapies, which helps mitigate risks associated with individual product fluctuations.

Negative

There is uncertainty in the market due to potential tariff impacts, which could affect drug pricing and procurement costs.
The company faces challenges in collecting out-of-pocket costs from patients, which could impact revenue collection.
Option Care Health Inc (OPCH) anticipates a $60 million to $70 million impact from Stelara inventory adjustments throughout the year.
The company is cautious about the potential lag between procurement costs and reimbursement adjustments, which could affect financial performance.
There is ongoing uncertainty regarding regulatory changes, such as Medicaid cuts and site-neutral payment policies, which could impact the business.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

OPCH.OQ - Option Care Health Inc
Q1 2025 Option Care Health Inc Earnings Call
Apr 29, 2025 / 12:30PM GMT

=====================
Conference Call Participants
=====================
* Lisa Gill
* Michael Shapiro
* John Rademacher
* Pito Chickering
* Constantine Davides
* David MacDonald
* Matthew Larew
* Jack Slevin
* Joanna Gajuk
* Albert Rice

=====================
Questions and Answers
--------------------------------------------------------------------------------
Operator [1]
--------------------------------------------------------------------------------
[Operator Instructions] Our first question comes from the line of Lisa Gill with JPMorgan.

--------------------------------------------------------------------------------
Lisa Gill, [2]
--------------------------------------------------------------------------------
Mike, I just want to go back to the guidance update, talking about no impact thus far for tariffs. But you

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.